Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

Express Scripts (ESI) has slashed pharmacy reimbursements for 2023, making it impossible for many independent community pharmacies to participate in the TRICARE pharmacy network.

ESI has also notified TRICARE beneficiaries that their pharmacy will no longer be in network as of October 24, 2022, instead of the end of December this year. ESI’s actions are creating disruptions for TRICARE beneficiaries and their caregivers, and making it more difficult for many to access their necessary prescriptions.

If you would like to take action, NCPA and APC are encouraging pharmacists to use this link to urge your federal legislators to sign on to a letter led by Sen. Tom Cotton (R-Ark.) and Rep. Buddy Carter (R-Ga.) that demands answers from the Department of Defense on the recent TRICARE pharmacy contracts. Don’t delay, as the deadline for Members of Congress to sign on is September 28.

For your patients and their caregivers who are experiencing a disruption, please direct them to this NCPA-created resource to take action. Print this letter in your pharmacy and ask your affected patients to sign and mail directly to the Defense Health Agency.